Epigenomics AG: Noel Doheny Appointed as New CEO of US-Subsidiary Epigenomics Inc.
Mr. Doheny has 30+ years of experience in the field of diagnostics, with over 20 years in senior management. In his most recent position as CEO of OpGen (2008-2009), Mr. Doheny led the transformation of an incubator lab services company into a systems company in less than two years. Prior to this, he held positions as Senior Vice President for the Molecular Diagnostics Division of Affymetrix Inc., Vice President of Pre-Analytical Solutions and a member of the Executive Committee at QIAGEN as well as President and CEO of BioStar Inc. (known as ThermoBioStar post-acquisition). Importantly for Epigenomics as it continues to build a US sales force, he has built several operating teams from the ground up, including the commercial teams to launch novel products at companies such as Ciba Corning, ThermoBiostar, and OpGen. Mr. Doheny obtained degrees in Biology and Chemistry from West Virginia University and attended Georgetown University for post-graduate studies in Biochemistry prior to moving into industry.
Most read news
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.